SAN DIEGO (AP) — Cytori Therapeutics Inc. (CYTX) on Thursday reported a loss of $4.4 million in its first quarter. On a per-share basis, the San Diego-based company said it had a loss of 7 cents. The developer of cell therapies posted …
Mr. Seijiro N. Shirahama is President, Asia Pacific of Cytori Therapeutics Inc. Mr. Shirahama had served as Senior Vice President – Asia Pacific since November 2006, and as Vice President – Asia Pacific, from September 2002 to …
SAN DIEGO, May 07, 2018 (GLOBE NEWSWIRE) -- Cytori Therapeutics, Inc. (NASDAQ:CYTX) will provide a live webcast of its first quarter financial results and business update on Thursday, May 10, 2018 at 5:30 PM Eastern Time. The dial …
A year ago, they were trading at $1.55. This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CYTX at https://www.zacks.com/ap/CYTX
Cytori Therapeutics, Inc. (Cytori) is a biotechnology company engaged in the development of treatments and devices for a range of disorders using cells as a key part of the therapy. The Company develops cellular therapeutics formulated and …
CYTX is still a bargain right now. I’ve used the price-to-book ratio in this instance because there’s not enough visibility to forecast its cash flows, and its earnings doesn’t seem to reflect its true value. The stock’s ratio of 1.4x is currently ...
Investors in Cytori Therapeutics, Inc. CYTX need to pay close attention to the stock based on moves in the options market lately. That is because the December 15 th, 2017, $2 Call had some of the highest implied volatility of all equity options …